Found: 15
Select item for more details and to access through your institution.
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-36910-5
- By:
- Publication type:
- Article
Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33284-y
- By:
- Publication type:
- Article
Asprosin-neutralizing antibodies as a treatment for metabolic syndrome.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.63784
- By:
- Publication type:
- Article
Blocking LAIR1 signaling in immune cells inhibits tumor development.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.996026
- By:
- Publication type:
- Article
Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Neutralizing Antibodies Induced by Recombinant Virus-Like Particles of Enterovirus 71 Genotype C4 Inhibit Infection at Pre- and Post-attachment Steps.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0057601
- By:
- Publication type:
- Article
Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00593-y
- By:
- Publication type:
- Article
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00860-w
- By:
- Publication type:
- Article
Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 3, p. 1, doi. 10.1371/journal.ppat.1005454
- By:
- Publication type:
- Article
Antibody therapies for the treatment of COVID-19.
- Published in:
- Antibody Therapeutics, 2020, v. 3, n. 2, p. 101, doi. 10.1093/abt/tbaa007
- By:
- Publication type:
- Article
Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment step.
- Published in:
- PLoS Pathogens, 2020, v. 16, n. 8, p. 1, doi. 10.1371/journal.ppat.1008736
- By:
- Publication type:
- Article
Identification of adipocyte plasma membrane-associated protein as a novel modulator of human cytomegalovirus infection.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 7, p. 1, doi. 10.1371/journal.ppat.1007914
- By:
- Publication type:
- Article
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.
- Published in:
- BioDrugs, 2022, v. 36, n. 3, p. 231, doi. 10.1007/s40259-022-00529-7
- By:
- Publication type:
- Article
Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20789-7
- By:
- Publication type:
- Article
LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions.
- Published in:
- Molecular Neurodegeneration, 2022, v. 17, n. 1, p. 1, doi. 10.1186/s13024-022-00550-y
- By:
- Publication type:
- Article